Načítá se...
Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m(2) Prior to Bariatric Surgery
FDA approved anti-obesity medications may not be cost effective for patients struggling with pre-operative weight loss prior to bariatric surgery. Metformin, a biguanide, and Topiramate, a carbonic anhydrase inhibitor, both cost effective medications, have demonstrated weight loss when used for the...
Uloženo v:
| Vydáno v: | Front Endocrinol (Lausanne) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947603/ https://ncbi.nlm.nih.gov/pubmed/33716960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.588016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|